{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:01:05Z","timestamp":1785326465706,"version":"3.55.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>People living with human immunodeficiency virus (HIV) accounted for a large share of cases during the 2022 multinational mpox outbreak, but whether adverse outcomes are attributable to HIV infection itself or to the degree of immune dysfunction remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review and meta-analysis according to PRISMA 2020 and Cochrane methods. PubMed, Embase, and Web of Science were searched from inception through January 31, 2026, with targeted literature updating through May 27, 2026. Observational studies reporting mpox outcomes stratified by HIV status were eligible. The primary outcome was hospitalization. Risk ratios (RRs) were pooled using DerSimonian-Laird random-effects models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty studies were included in the qualitative synthesis and 13 studies comprising 32,685 participants were included in the hospitalization meta-analysis. HIV infection was associated with increased hospitalization risk (RR, 1.40; 95% CI, 1.07\u20131.85; I\n                      <jats:sup>2<\/jats:sup>\n                      = 81%). The 95% prediction interval was wide (0.54\u20133.65), indicating that context, case mix, and hospitalization thresholds influenced observed effects. CD4-stratified evidence was not sufficiently uniform for a valid pooled CD4-specific effect estimate, but available studies consistently indicated that low CD4 count, uncontrolled HIV viremia, and disengagement from HIV care identify the subgroup at greatest risk for hospitalization, severe disease, prolonged infection, and death.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Adverse mpox outcomes among people living with HIV are better explained by immune status and HIV disease control than by HIV serostatus alone. CD4-based risk stratification provides a clinically actionable framework for triage, follow-up intensity, antiviral-treatment consideration, and integration of mpox management with HIV care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1895518","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:10:34Z","timestamp":1785323434000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune dysfunction drives adverse mpox outcomes among people living with human immunodeficiency virus: a systematic review and meta-analysis with CD4-based risk stratification"],"prefix":"10.3389","volume":"13","author":[{"given":"Chunting","family":"Qiu","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, The Second People\u2019s Hospital of Tianjin Medical University","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defa","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Second People\u2019s Hospital of Tianjin Medical University","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Second People\u2019s Hospital of Tianjin Medical University","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Second People\u2019s Hospital of Tianjin Medical University","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Second People\u2019s Hospital of Tianjin Medical University","place":["Tianjin, China"]},{"name":"State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1012","DOI":"10.1016\/S2214-109X(23)00198-5","article-title":"Description of the first global outbreak of mpox: an analysis of global surveillance data.","volume":"11","author":"Laurenson-Schafer","year":"2023","journal-title":"Lancet Glob Health."},{"key":"B2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries - April-June 2022.","volume":"387","author":"Thornhill","year":"2022","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S1473-3099(22)00651-X","article-title":"Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study.","volume":"23","author":"Angelo","year":"2023","journal-title":"Lancet Infect Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(23)00273-8","article-title":"Mpox in people with advanced HIV infection: a global case series.","volume":"401","author":"Mitj\u00e0","year":"2023","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.3390\/microorganisms11112701","article-title":"Mpox: clinical outcomes and impact of vaccination in people with and without HIV: a population-wide study.","volume":"11","author":"Mart\u00edn-Iguacel","year":"2023","journal-title":"Microorganisms."},{"key":"B6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/cid\/ciad482","article-title":"Low CD4 count or being out of care increases the risk for Mpox hospitalization among people with human immunodeficiency virus and Mpox.","volume":"78","author":"Philpott","year":"2024","journal-title":"Clin Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"ofae294","DOI":"10.1093\/ofid\/ofae294","article-title":"Severe Mpox among people with advanced human immunodeficiency virus receiving prolonged tecovirimat in New York City.","volume":"11","author":"Garcia","year":"2024","journal-title":"Open Forum Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12985-024-02392-0","article-title":"The impact of immunosuppression on the mortality and hospitalization of Monkeypox: a systematic review and meta-analysis of the 2022 outbreak.","volume":"21","author":"Azzam","year":"2024","journal-title":"Virol J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12879-025-10512-6","article-title":"Association of HIV infection and hospitalization among mpox cases: a systematic review and meta-analysis.","volume":"25","author":"Shabil","year":"2025","journal-title":"BMC Infect Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1751445","DOI":"10.3389\/fmicb.2026.1751445","article-title":"The impact of human immunodeficiency virus coinfection on mpox patients during the 2022 global outbreak: a systematic review and meta-analysis based on comparative observational studies.","volume":"17","author":"Han","year":"2026","journal-title":"Front Microbiol."},{"key":"B11","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5.","author":"Higgins","year":"2024"},{"key":"B12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"B13","doi-asserted-by":"publisher","first-page":"9971","DOI":"10.1038\/s41598-026-37209-3","article-title":"Mpox in people living with and without HIV, including people on PrEP, during a multistate outbreak in Spain in 2022.","volume":"16","author":"March-Yag\u00fce","year":"2026","journal-title":"Sci Rep."},{"key":"B14","volume-title":"The Newcastle-Ottawa Scale for Assessing the Quality of Nonrandomised Studies in Meta-Analyses.","author":"Wells","year":"2011"},{"key":"B15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/hiv.13378","article-title":"Clinical characteristics of monkeypox virus infections among men with and without HIV: a large outbreak cohort in Germany.","volume":"24","author":"Hoffmann","year":"2023","journal-title":"HIV Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e30564","DOI":"10.1016\/j.heliyon.2024.e30564","article-title":"Hospitalization determinants in patients with Mpox disease: the CEME-22 Project.","volume":"10","author":"Ramirez-Olivencia","year":"2024","journal-title":"Heliyon"},{"key":"B17","doi-asserted-by":"publisher","first-page":"102494","DOI":"10.1016\/j.jiph.2024.102494","article-title":"Epidemiological and clinical characteristics of monkeypox among people with and without HIV in Peru: a national observational study.","volume":"17","author":"Ram\u00edrez-Soto","year":"2024","journal-title":"J Infect Public Health."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2200923","DOI":"10.2807\/1560-7917.ES.2023.28.50.2200923","article-title":"Mpox outbreak in France: epidemiological characteristics and sexual behaviour of cases aged 15 years or older, 2022.","volume":"28","author":"Krug","year":"2023","journal-title":"Euro Surveill."},{"key":"B19","doi-asserted-by":"publisher","first-page":"ofad533","DOI":"10.1093\/ofid\/ofad533","article-title":"Risk factors for hospitalization and effect of immunosuppression on clinical outcomes among an urban cohort of patients with Mpox.","volume":"10","author":"Garneau","year":"2023","journal-title":"Open Forum Infect Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"100406","DOI":"10.1016\/j.lana.2022.100406","article-title":"Ambulatory and hospitalized patients with suspected and confirmed mpox: an observational cohort study from Brazil.","volume":"17","author":"Silva","year":"2022","journal-title":"Lancet Reg Health Am."},{"key":"B21","doi-asserted-by":"publisher","first-page":"992","DOI":"10.15585\/mmwr.mm7236a4","article-title":"Reduced odds of mpox-associated hospitalization among persons who received JYNNEOS vaccine - California, May 2022-May 2023.","volume":"72","author":"Schildhauer","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"20499361231196683","DOI":"10.1177\/20499361231196683","article-title":"Hospitalization risk among patients with Mpox infection-a propensity score matched analysis.","volume":"10","author":"Henao-Mart\u00ednez","year":"2023","journal-title":"Ther Adv Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/QAD.0000000000003449","article-title":"Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: a retrospective cohort.","volume":"37","author":"Chastain","year":"2023","journal-title":"AIDS."},{"key":"B24","doi-asserted-by":"publisher","first-page":"100859","DOI":"10.1016\/S2666-5247(24)00074-0","article-title":"Immune responses associated with mpox viral clearance in men with and without HIV in Spain: a multisite, observational, prospective cohort study.","volume":"5","author":"Moraes-Cardoso","year":"2024","journal-title":"Lancet Microbe."},{"key":"B25","article-title":"Mpox: Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV.","year":"2025"},{"key":"B26","volume-title":"Mpox Clinical Care for People with HIV.","year":"2026"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.15585\/mmwr.mm7132e4","article-title":"Interim guidance for prevention and treatment of monkeypox in persons with HIV infection - United States, August 2022.","volume":"71","author":"O\u2019Shea","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B28","volume-title":"WHO Recommends Rapid Treatment Initiation for People Living with HIV and Mpox.","year":"2025"},{"key":"B29","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/hiv.13622","article-title":"The effect of HIV and mpox co-infection on clinical outcomes: systematic review and meta-analysis.","volume":"25","author":"Taha","year":"2024","journal-title":"HIV Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1895518\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:10:39Z","timestamp":1785323439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1895518\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":29,"alternative-id":["10.3389\/fmed.2026.1895518"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1895518","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"article-number":"1895518"}}